Skip to main content

Table 1 Demographics and clinical presentations of hepatoid carcinoma of the pancreas

From: Hepatoid carcinoma of the pancreas

  Total Pancreatic head Pancreatic body-tail P value
Sex n = 23 n = 9 n = 14 0.418
Male 16 (69.6 %) 7 (77.8 %) 9 (64.3 %)  
Female 7 (30.4 %) 2 (22.2 %) 5 (35.7 %)
Age (year) n = 23 n = 9 n = 14 0.156
Median (range) 56 (21–80) 49 (21–80) 58 (32–79)  
Mean ± SD 53.8 ± 14.9 48.2 ± 17.5 57.4 ± 12.3
Size (cm) n = 20 n = 8 n = 12 0.907
Median (range) 6.0 (0.5–11.0) 6.3 (0.5–9.0) 6.0 (1.0–11.0)  
Mean ± SD 5.5 ± 2.7 5.6 ± 2.8 5.5 ± 2.8
Hepatitis B (+), n = 8 0 0 0 N/A
Hepatitis C (+), n = 8 0 0 0 N/A
Elevation of tumor markers     
AFP, n = 15 9 (60.0 %) 5 (71.4 %) 4 (50.0 %) 0.378
CA 19-9, n = 11 2 (18.2 %) 1 (25.0 %) 1 (14.3 %) 0.618
CEA, n = 11 2 (18.2 %) 1 (25.0 %) 1 (14.3 %) 0.618
Symptom n = 22 n = 9 n = 14  
No symptom 7 (31.8 %) 1 (12.5 %) 6 (42.9 %) 0.161
Epigastric pain 8 (36.4 %) 4 (50.0 %) 4 (28.6 %) 0.291
Nausea/vomiting 7 (31.8 %) 5 (62.5 %) 2 (14.3 %) 0.032
Diabetes mellitus 5 (22.7 %) 1 (12.5 %) 4 (28.6 %) 0.308
Jaundice 4 (18.2 %) 4 (50.0 %) 0 0.010
Back pain 4 (18.2 %) 2 (25.0 %) 2 (14.3 %) 0.465
Body weight loss 3 (13.6 %) 1 (12.5 %) 2 (14.3 %) 0.797
Hypoglycemia 1 (4.5 %) 0 1 (7.1 %) 0.636
Skin rash 1 (4.5 %) 0 1 (7.1 %) 0.636
Subcutaneous fat necrosis 1 (4.5 %) 0 1 (7.1 %) 0.636
Gastrointestinal bleeding 1 (4.5 %) 0 1 (7.1 %) 0.636
Night sweating 1 (4.5 %) 0 1 (7.1 %) 0.636
Others 2 (15.4 %) 0 2 (14.3 %) 0.462
  1. N/A not available, AFP alpha-fetoprotein, CA 19-9 carbohydrate antigen 19-9, CEA carcinoembryonic antigen